NM_003995.4:c.18T>C

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_003995.4(NPR2):​c.18T>C​(p.Leu6Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.221 in 1,610,820 control chromosomes in the GnomAD database, including 42,415 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.28 ( 6861 hom., cov: 32)
Exomes 𝑓: 0.21 ( 35554 hom. )

Consequence

NPR2
NM_003995.4 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.275

Publications

16 publications found
Variant links:
Genes affected
NPR2 (HGNC:7944): (natriuretic peptide receptor 2) This gene encodes natriuretic peptide receptor B, one of two integral membrane receptors for natriuretic peptides. Both NPR1 and NPR2 contain five functional domains: an extracellular ligand-binding domain, a single membrane-spanning region, and intracellularly a protein kinase homology domain, a helical hinge region involved in oligomerization, and a carboxyl-terminal guanylyl cyclase catalytic domain. The protein is the primary receptor for C-type natriuretic peptide (CNP), which upon ligand binding exhibits greatly increased guanylyl cyclase activity. Mutations in this gene are the cause of acromesomelic dysplasia Maroteaux type. [provided by RefSeq, Jul 2008]
NPR2 Gene-Disease associations (from GenCC):
  • acromesomelic dysplasia 1, Maroteaux type
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
  • short stature with nonspecific skeletal abnormalities 1
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • tall stature-scoliosis-macrodactyly of the great toes syndrome
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.62).
BP6
Variant 9-35792426-T-C is Benign according to our data. Variant chr9-35792426-T-C is described in ClinVar as [Benign]. Clinvar id is 366776.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.275 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.447 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NPR2NM_003995.4 linkc.18T>C p.Leu6Leu synonymous_variant Exon 1 of 22 ENST00000342694.7 NP_003986.2 P20594-1
NPR2NM_001378923.1 linkc.18T>C p.Leu6Leu synonymous_variant Exon 1 of 22 NP_001365852.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NPR2ENST00000342694.7 linkc.18T>C p.Leu6Leu synonymous_variant Exon 1 of 22 1 NM_003995.4 ENSP00000341083.2 P20594-1

Frequencies

GnomAD3 genomes
AF:
0.276
AC:
41861
AN:
151846
Hom.:
6836
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.452
Gnomad AMI
AF:
0.153
Gnomad AMR
AF:
0.248
Gnomad ASJ
AF:
0.255
Gnomad EAS
AF:
0.368
Gnomad SAS
AF:
0.185
Gnomad FIN
AF:
0.156
Gnomad MID
AF:
0.222
Gnomad NFE
AF:
0.196
Gnomad OTH
AF:
0.252
GnomAD2 exomes
AF:
0.229
AC:
56287
AN:
245782
AF XY:
0.222
show subpopulations
Gnomad AFR exome
AF:
0.458
Gnomad AMR exome
AF:
0.228
Gnomad ASJ exome
AF:
0.248
Gnomad EAS exome
AF:
0.359
Gnomad FIN exome
AF:
0.163
Gnomad NFE exome
AF:
0.198
Gnomad OTH exome
AF:
0.220
GnomAD4 exome
AF:
0.215
AC:
313310
AN:
1458856
Hom.:
35554
Cov.:
38
AF XY:
0.213
AC XY:
154569
AN XY:
725780
show subpopulations
African (AFR)
AF:
0.462
AC:
15457
AN:
33454
American (AMR)
AF:
0.231
AC:
10319
AN:
44636
Ashkenazi Jewish (ASJ)
AF:
0.249
AC:
6499
AN:
26088
East Asian (EAS)
AF:
0.330
AC:
13110
AN:
39674
South Asian (SAS)
AF:
0.186
AC:
16044
AN:
86180
European-Finnish (FIN)
AF:
0.167
AC:
8548
AN:
51328
Middle Eastern (MID)
AF:
0.206
AC:
1151
AN:
5588
European-Non Finnish (NFE)
AF:
0.205
AC:
228021
AN:
1111594
Other (OTH)
AF:
0.235
AC:
14161
AN:
60314
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.479
Heterozygous variant carriers
0
14915
29830
44746
59661
74576
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8274
16548
24822
33096
41370
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.276
AC:
41922
AN:
151964
Hom.:
6861
Cov.:
32
AF XY:
0.274
AC XY:
20326
AN XY:
74276
show subpopulations
African (AFR)
AF:
0.453
AC:
18754
AN:
41424
American (AMR)
AF:
0.247
AC:
3779
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.255
AC:
883
AN:
3464
East Asian (EAS)
AF:
0.368
AC:
1886
AN:
5126
South Asian (SAS)
AF:
0.185
AC:
892
AN:
4830
European-Finnish (FIN)
AF:
0.156
AC:
1652
AN:
10594
Middle Eastern (MID)
AF:
0.221
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
0.196
AC:
13347
AN:
67930
Other (OTH)
AF:
0.249
AC:
525
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1470
2940
4409
5879
7349
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
408
816
1224
1632
2040
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.234
Hom.:
2611
Bravo
AF:
0.295
Asia WGS
AF:
0.264
AC:
916
AN:
3478
EpiCase
AF:
0.199
EpiControl
AF:
0.210

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jun 09, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Acromesomelic dysplasia 1, Maroteaux type Benign:1
Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

Acromesomelic dysplasia 1, Maroteaux type;C4014690:Tall stature-scoliosis-macrodactyly of the great toes syndrome Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.62
CADD
Benign
9.6
DANN
Benign
0.73
PhyloP100
-0.28
PromoterAI
-0.0052
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2228580; hg19: chr9-35792423; COSMIC: COSV61308899; COSMIC: COSV61308899; API